EXEL

Exelixis (EXEL)

About Exelixis (EXEL)

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Details

Daily high

$41.77

Daily low

$40.83

Price at open

52 Week High

$49.62

52 Week Low

$31.90

Market cap

11.2B

Dividend yield

0.00%

Volume

1,529

Avg. volume

2.7M

P/E ratio

17.51

Exelixis News